Cargando…
Correction: ‘Do bisphosphonates and RANKL inhibitors alter the progression of coronary artery calcification? A systematic review and meta-analysis protocol’
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814994/ https://www.ncbi.nlm.nih.gov/pubmed/36596639 http://dx.doi.org/10.1136/bmjopen-2022-066255corr1 |
Ejemplares similares
-
Do bisphosphonates and RANKL inhibitors alter the progression of coronary artery calcification? A systematic review and meta-analysis protocol
por: Saunders, Samantha Louise, et al.
Publicado: (2022) -
Correction: TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL
por: Di Bartolo, Belinda A., et al.
Publicado: (2013) -
Correction to: The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis
por: Zheng, Zaoqian, et al.
Publicado: (2020) -
Correction: Genome-Wide Association Study of Gene by Smoking Interactions in Coronary Artery Calcification
Publicado: (2014) -
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?
por: Orsolini, Giovanni, et al.
Publicado: (2018)